541 Characterization of myeloid cell subsets in the tumor microenvironment of merkel cell carcinoma

Tabachnick-Cherny, S. ; Pulliam, T. ; Smythe, K. ; Nghiem, P.

Texto completo disponível

434 Novel management approaches for oligometastatic merkel cell carcinoma when standard systemic therapy is not an option

McClure, E. ; Akaike, T. ; Huynh, E.T. ; Harikrishnan, N. ; Lachance, K. ; Church, C. ; Pulliam, T. ; Nghiem, P.

Elsevier Inc

Texto completo disponível

143 Genetic and transcriptional signatures of merkel cell carcinoma-specific B cells suggest a functional role in modulating cancer immunity

Remington, A.J. ; Rodriguez, H.J. ; Pulliam, T. ; Gray, M.D. ; Taylor, J.J. ; Nghiem, P.

Elsevier Inc

Texto completo disponível

848 Inhibition of ATR augments immunogenicity in merkel cell carcinoma: A promising approach to address resistance to anti-PD-1 immunotherapy

Bhakuni, R. ; Goff, P. ; Lee, J.H. ; Pulliam, T. ; Tabachnick-Cherny, S. ; Morningstar, C.D. ; Nghiem, P.

Texto completo disponível

LB879 Friend or foe? Identification of MCPyV-specific B cells in Merkel cell carcinomas suggests a functional role in tumor immunity

Chevez, H. J. Rodriguez ; Pulliam, T. ; Remington, A. ; Nghiem, P. ; Taylor, J.

Texto completo disponível

LB820 ATR inhibition for potentiation of immunogenicity and cell death in Merkel Cell Carcinoma refractory to PD-1 pathway blockade

Bhakuni, R. ; Goff, P. ; Lee, J. ; Pulliam, T. ; Cherny, S. ; Morningstar, C.D. ; Nghiem, P.

Elsevier Inc

Texto completo disponível

865 Immunotherapy in advanced Merkel cell carcinoma: Frequent responses but a potentially concerning recurrence rate after therapy discontinuation

Moshiri, Y. ; Alexander, N. ; Akaike, T. ; Doolittle-Amieva, C. ; Pulliam, T. ; Zaba, L. ; Nghiem, P.

Elsevier Inc

Texto completo disponível

LB1029 Correlation of merkel virus-specific CD8 T cells with response to immunotherapy in merkel cell carcinoma

Pulliam, T. ; Jani, S. ; Jing, L. ; Zhang, J. ; Kulikauskas, R. ; Church, C. ; Garnett-Benson, C. ; Paulson, K. ; Pardoll, D. ; Koelle, D. ; Topalian, S. ; Nghiem, P.

Texto completo disponível

292 Is it safe to discontinue immunotherapy after a response in merkel cell carcinoma?

Tachiki, L. ; Zawacki, L. ; Hippe, D. ; Moshiri, Y. ; Alexander, N. ; Akaike, T. ; Doolittle-Amieva, C. ; Pulliam, T. ; Zaba, L. ; Bhatia, S. ; Nghiem, P.

Texto completo disponível

LB1044 Inhibitors of CDK4/6 and HIF2a induce immunogenic cell death in merkel cell carcinoma cells

Lee, J.H. ; Lee, J. ; Pulliam, T. ; Paulson, K. ; Voillet, V. ; Berndt, A. ; Church, C. ; Lachance, K. ; Park, S.Y. ; Cromwell, E. ; Gottardo, R. ; Chapuis, A. ; Nghiem, P.

Texto completo disponível